|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.140 EUR | 0.00% |
|
-5.00% | -22.45% |
| 06/07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Company Valuation: Laboratorio Farmaceutico Erfo S.p.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 18.27 | 11.79 | 10.8 | 12.53 |
| Change | - | -35.47% | -8.4% | 16.03% |
| Enterprise Value (EV) 1 | 17.38 | 11.41 | 10.81 | 12.83 |
| Change | - | -34.34% | -5.31% | 18.7% |
| P/E | 25.5x | 19.1x | 30.8x | 17x |
| PBR | 2.33x | 1.43x | 1.44x | 1.57x |
| PEG | -0.3x | -1.4x | -0.8x | 0x |
| Capitalization / Revenue | 3.87x | 1.99x | 1.79x | 1.29x |
| EV / Revenue | 3.68x | 1.92x | 1.79x | 1.32x |
| EV / EBITDA | 11.8x | 8.02x | 10.1x | 7x |
| EV / EBIT | 17.6x | 13.6x | 20.6x | 12x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | 0.06 | - | - |
| Rate of return | - | 4.58% | - | - |
| EPS 2 | 0.0796 | 0.0686 | 0.0411 | 0.0865 |
| Distribution rate | - | 87.4% | - | - |
| Net sales 1 | 4.719 | 5.932 | 6.032 | 9.732 |
| EBITDA 1 | 1.474 | 1.423 | 1.065 | 1.832 |
| EBIT 1 | 0.987 | 0.8367 | 0.5239 | 1.066 |
| Net income 1 | 0.7161 | 0.5903 | 0.3528 | 0.737 |
| Net Debt 1 | -0.8895 | -0.3784 | 0.005767 | 0.2954 |
| Reference price 2 | 2.030 | 1.310 | 1.265 | 1.470 |
| Nbr of stocks (in thousands) | 9,000 | 9,000 | 8,537 | 8,524 |
| Announcement Date | 12/04/23 | 08/05/24 | 14/04/25 | 12/04/26 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.1Cr | |
| 35.39x | 12.58x | 26.43x | 0.57% | 1,05700Cr | |
| 27.79x | 6.35x | 17.58x | 2.07% | 62TCr | |
| 33.47x | 7.59x | 15.59x | 2.68% | 45TCr | |
| 20.98x | 4.63x | 11.4x | 2.86% | 34TCr | |
| 21.62x | 5.7x | 13.97x | 2.82% | 30TCr | |
| 21.08x | 4.45x | 12.3x | 1.98% | 26TCr | |
| 14.13x | 5.26x | 10.83x | 3.54% | 22TCr | |
| 24.37x | 6.41x | 11.32x | 2.71% | 20TCr | |
| -47.14x | 5.65x | 31.2x | 2.52% | 16TCr | |
| Average | 16.85x | 6.51x | 16.74x | 2.42% | 36.14TCr | |
| Weighted average by Cap. | 24.72x | 7.88x | 18.52x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ERFO Stock
- Valuation Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions
